Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.88 +0.02 (+1.34%)
As of: Nov 11, 2026 · 11:04 AM EST

Lexicon Pharmaceuticals (LXRX) Return on Equity [ROE] (2009 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) recorded Return on Equity [ROE] of -28.88% in Q2 2026, up 64.89 percentage points from -93.77% a year earlier but down 13.27 percentage points from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Return on Equity [ROE] (2009 - 2026) Analysis & Trends

For FY2025, Lexicon Pharmaceuticals reported Return on Equity [ROE] of -38.59%, up 126.32 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of +4.25 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -164.91% in FY2024 (-1.52 pp), -163.39% in FY2023 (-73.64 pp), -89.75% in FY2022 (-24.74 pp) and -65.01% in FY2021 (-22.18 pp).
  • Quarterly Return on Equity [ROE] has ranged from -154.27% in Q4 2023 to -15.61% in Q1 2026 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of +36.29 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 225.51 percentage points in Q3 2021, against a drop of 144.79 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -15.61% (Q1 2026), -42.96% (Q4 2025) and -53.58% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Lexicon Pharmaceuticals 831.26 Mn 190.55 Mn 11.17 Mn -37.06%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -37.06%
Jun 30, 2026 -32.49%
Mar 31, 2026 -16.91%
Dec 31, 2025 -44.30%
Sep 30, 2025 -55.21%
Jun 30, 2025 -95.41%
Mar 31, 2025 -131.78%
Dec 31, 2024 -123.48%
Sep 30, 2024 -103.19%
Jun 30, 2024 -76.47%
Mar 31, 2024 -101.30%
Dec 31, 2023 -151.89%
Sep 30, 2023 -96.65%
Jun 30, 2023 -95.24%
Mar 31, 2023 -107.74%
Dec 31, 2022 -78.40%
Sep 30, 2022 -81,705.94%
Jun 30, 2022 -107,346.97%
Mar 31, 2022 -85,087.28%
Dec 31, 2021 -70,154.04%
API Access

Lexicon Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LXRX&period=max&api_key=YOUR_API_KEY